ClinicalTrials.Veeva

Menu

Multiple Risk Factor Intervention Trial (Ms FIT)

U

University of Toronto

Status

Completed

Conditions

Metabolic Disturbance
Sedentary Behavior

Treatments

Behavioral: Experimental: Guidelines-based healthy eating
Behavioral: Stretching exercise
Behavioral: Experimental: Guidelines-based physical activity

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Ms. FIT pilot is a pilot study of a 3-arm RCT with equal recruitment and stratification of pre and postmenopausal women with risk factors for chronic disease to: 1) Canadian guidelines-based physical activity alone; 2) Canadian guidelines-based physical activity and healthy eating; or 3) stretching attention control. The purpose of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of the interventions. The objectives are to: 1) pilot test the intervention delivery protocol in a real-world application (management and technical capabilities of the research group); 2) evaluate adherence and participant acceptability of a combined in-person and virtual intervention delivery in both pre and post-menopausal women; 3) identify the preliminary efficacy of the interventions on select cardiometabolic risk markers.

Enrollment

30 patients

Sex

Female

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • females
  • pre- or postmenopausal
  • aged 30+ years
  • moderate or high Canadian Diabetes Risk Score score

Exclusion criteria

  • diagnoses of cardiovascular diseases, type 2 diabetes, non-alcoholic fatty liver disease, cancer (except for non-melanoma skin cancer), or respiratory disease (i.e., COPD)
  • major signs or symptoms (regardless of known diagnosis) of cardiovascular diseases, diabetes, or renal disease
  • pregnant or lactating
  • mobility limitations to exercise
  • smoking cigarettes within the past 3 months
  • using transdermal hormones, taking exogenous hormones or receiving exogenous hormones from other means (e.g. intrauterine device)
  • self-report of >30 min/week of MVPA
  • following a specific dietary practice (e.g., vegan, ketogenic) in last 3 months
  • presenting with any of the American Heart Association's absolute or relative contraindications for symptom-limited maximal exercise testing
  • requiring and do not receive medical clearance for maximal exercise
  • cannot read and understand the consent form or communicate in English
  • individuals who are students in classes of the professors who are involved in the study or students with whom the professors have a supervisory relationship

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 3 patient groups, including a placebo group

Guidelines-based physical activity
Experimental group
Description:
150 weekly minutes of moderate-intensity aerobic activity and twice weekly whole-body muscle strengthening
Treatment:
Behavioral: Experimental: Guidelines-based physical activity
Guidelines-based physical activity and healthy eating
Experimental group
Description:
150 weekly minutes of moderate-intensity aerobic activity and twice weekly whole-body muscle strengthening + counselling to follow Canada's Food Guide
Treatment:
Behavioral: Experimental: Guidelines-based physical activity
Behavioral: Experimental: Guidelines-based healthy eating
Stretching exercise
Placebo Comparator group
Description:
Whole-body stretching
Treatment:
Behavioral: Stretching exercise

Trial contacts and locations

1

Loading...

Central trial contact

Amy A Kirkham, PhD; Jenna B Gillen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems